Increases in aesthetic experience following ayahuasca use: An open-label, naturalistic study
Jacob S. Aday, Emily K. Bloesch, Alan K. Davis, Sarah E. Domoff, Kyle C Scherr, Joshua Woolley, Christopher C. Davoli
May 15, 2023 preprint DOI: 10.31234/osf.io/gd8h2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Open-label longitudinal study |
|---|---|
| Sample size | 54 |
| Population | Adults attending an ayahuasca retreat center |
| Intervention | Ayahuasca |
| Duration | One-month follow-up |
| Topics | Ayahuasca Mysticism |
| Keywords | Perception Psychotherapist Clinical psychology |
| Citations | 3 |
| Key findings | Participants showed increased levels of aesthetic experience at one-week and one-month follow-ups compared to baseline, and acute drug effects did not predict this change. |
Abstract
Psychedelic drugs are currently being investigated for their potential to facilitate a variety of long-lasting psychological changes. One area of psychological functioning that has yet to be systematically investigated in psychedelic research regards aesthetic experiences. This is surprising given the notable acute changes in perception induced by the drugs as well as the wealth of anecdotal reports of individuals reporting increased engagement in aesthetic experiences after psychedelic use. The current study was designed to address this gap in the literature by administering a validated measure of aesthetic experience one-week before, one-week after, and one-month after participants (N = 54) attended an ayahuasca retreat center. Participants also completed surveys indexing the extent to which they endorsed mystical-type experiences, awe, and ego dissolution during their ayahuasca sessions to identify potential predictors of long-term change. We found that compared to baseline, participants exhibited increased levels of aesthetic experience at both follow-ups. Measures of acute drug effects did not predict changes in aesthetic experience. Although the study was limited by an open-label design, the results support anecdotal reports regarding changes in aesthetic experience after psychedelic use and provide important groundwork for future study.
Comparable studies
Other non-randomized and open-label trials on ayahuasca, most cited first.
Citations in the library
Cited by 2
Cites 34
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness Journal of Psychopharmacology September 28, 2011
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder JAMA Psychiatry August 24, 2022
and 29 more in the library